Skip to main content

Table 1 Patient and tumor characteristics

From: Feasibility of hippocampus-sparing VMAT for newly diagnosed glioblastoma treated by chemoradiation: pattern of failure analysis

Variables

Number

Percent

Total

82

(100.0)

Median age (years, range)

57.7

(24.0–86.0)

Sex

  

 Male

49

(59.8)

 Female

33

(40.2)

KPS

  

 90–100

48

(58.5)

 70–80

24

(29.3)

  < 70

10

(12.2)

Molecular profiles

  

MGMT promoter methylation

  

  Yes

37

(45.1)

  No

45

(54.9)

IDH1 mutation

  

 Yes

4

(4.9)

 No

78

(95.1)

Surgery

  

 GTR

34

(41.5)

 PR

33

(40.2)

 Biopsy

15

(18.3)

Location

  

 Right

43

(52.4)

 Left

33

(40.2)

 Bilateral

6

(7.3)

Subventricular zone involvement

  

 Yes

50

(61.0)

 No

32

(39.0)

Spatial relationship to the subventricular zone [19]

  

 Group I

34

(41.5)

 Group II

15

(18.3)

 Group III

28

(34.1)

 Group IV

5

(6.1)

Median PTV volumea (cc, range)

304.1

(85.1–648.9)

  1. Abbreviations: KPS Karnofsky Performance Score, MGMT methylated O6-methylguanine-DNA methyltransferase, IDH1 mutated isocitrate dehydrogenase 1, GTR gross total resection, PR partial resection, PTV planning target volume
  2. aThe volume of initial field for patients using a shrinking field technique